Ads
related to: what are the side effects of smoldering myeloma cancer- Disease Overview
Learn About Disease And Treatment
Progression For RRMM.
- Dosing Schedule
Find More Information On Dosing.
Create A Treatment Calendar.
- Combination Therapy
Understand Triplet
Combination Therapy.
- Triplet Data
Access Important Safety Data
For This Treatment Option.
- Nurse Dosing Resources
View Nurse Resources & Tools.
Download A Medication Guide.
- Renal Dosing
View Dosing Information Based
On Renal Impairment.
- Disease Overview
Search results
Results From The WOW.Com Content Network
Smouldering myeloma is a disease classified as intermediate in a spectrum of step-wise progressive diseases termed plasma cell dyscrasias. In this spectrum of diseases, a clone of plasma cells secreting monoclonal paraprotein (also termed myeloma protein or M protein) causes the relatively benign disease of monoclonal gammopathy of undetermined ...
MGUS is a relatively stable condition afflicting 3% of people aged 50 and 5% of people aged 70; it progresses to multiple myeloma at a rate of 0.5–1% cases per year; smoldering multiple myeloma does so at a rate of 10% per year for the first 5 years, but then falls off sharply to 3% per year for the next 5 years and thereafter to 1% per year.
Smoldering multiple myeloma or SMM (also termed smoldering myeloma) is the next stage following MGUS in the spectrum of plasma cell dyscrasias. While still considered a pre-malignant condition, its chances of progressing to a malignant plasma cell dyscrasia are generally greater than that for MGUS. [ 20 ]
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone. [8] It is taken by mouth. [8]
Kate Middleton is opening up about the long-term side effects of her cancer treatment. On Tuesday, Jan. 14, the Princess of Wales spoke with staff during a surprise visit to the Royal Marsden ...
Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell dyscrasia in which plasma cells or other types of antibody-producing cells secrete a myeloma protein, i.e. an abnormal antibody, into the blood; this abnormal protein is usually found during standard laboratory blood or urine tests.
Ads
related to: what are the side effects of smoldering myeloma cancer